OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Pharmaceutics is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Fluorophore-Conjugated Anti-ICOS Antibody Enables Precise Prediction of Therapeutic Response of the STING Agonist in Colorectal Cancer via NIRF Imaging	142
Solid-State Evaluation of a Newly Emerged Polymorph for Early-Stage Pharmaceutical Development	139
Issue Editorial Masthead	130
Issue Editorial Masthead	118
Issue Publication Information	110
Correction to “Effects of PEGylation on Imaging Contrast of ⁶⁸Ga-Labeled Bicyclic Peptide PET Probes Targeting Nectin-4”	86
Correction to Reshaping Tumor Blood Vessels to Enhance Drug Penetration with a Multistrategy Synergistic Nanosystem	81
Preclinical Safety Evaluation of Dual Drug-Loaded Nanolipidic Carriers of Dissolvable Patches: In-Vitro and In-Vivo Safety Assessment	81
Investigating Key Molecular Descriptors Affecting Particle Size: A Predictive Exemplary Approach for Self-Emulsifying System	80
Pharmacokinetic Bioequivalence between Generic and Originator Orally Inhaled Drug Products: Validity of Administration of Doses above the Approved Single Maximum Dose	72
[⁶⁸Ga]Ga-HM or [⁶⁸Ga]Ga-PM: Which Is Superior for PET/CT Imaging of HMGB1-Positive Tumors?	68
Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation	68
Structured Sponsorship: An Option for Improved Workplace Inclusion in the Pharmaceutical Sciences	64
Effects of Lyophilization, Vacuum Drying, and Microglassification on Two Model Proteins Assessed at the Residue Level Using Liquid Observed Vapor Exchange Nuclear Magnetic Resonance Spectroscopy (LOVE	63
Characterization of Peptide-Preservative Interaction and Reversibility by NMR Spectroscopy	61
Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment	59
Chiral and Dual Drugs Combination Reduces Tumor-Associated Neutrophils-Induced T-Cell Immunoparalysis to Treat Epithelial Ovarian Cancer	55
Correlating Differences in the Surface Activity to Interface-Induced Particle Formation in Different Protein Modalities: IgG mAb Versus Fc-Fusion Protein	54
Coupled Discrete Phase and Eulerian Wall Film Models for Drug Deposition Efficacy Analysis in Human Respiratory Airways	51
Influence of Nucleation on Relaxation, Molecular Cooperativity, and Physical Stability of Celecoxib Glass	51
Construction and Preclinical Evaluation of a ^124/125I-Labeled Specific Antibody Targeting PD-L2 in Lung Cancer	50
A Model Study to Assess Fibrillation and Product Stability to Support Peptide Drug Design	50
Photodynamic Therapeutic Monitoring of Glioblastoma Using High-Resolution Photoacoustic Vascular Imaging	49
Bridging the Gap between Food Effects under Clinical Trial Conditions and Real Life: Modeling Delayed Gastric Emptying of Drug Substances and Gastric Content Volume Based on Meal Characteristics	48
A Positron Emission Tomography Tracer Targeting the S2 Subunit of SARS-CoV-2 in Extrapulmonary Infections	47

Mechanical Extrusion of the Plasma Membrane to Generate Ectosome-Mimetic Nanovesicles for Lung Targeting	47
Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications	47
Predicting Experimental B₂₂ Values and the Effects of Histidine Charge States for Monoclonal Antibodies Using Coarse-Grained Molecular Simulations	47
Understanding the Roles of Excipients in Moisture Management in Solid Dosage Forms	46
Co-amorphous Systems of Sinomenine with Platensimycin or Sulfasalazine: Physical Stability and Excipient-Adjusted Release Behavior	46
Deconstructing Annealing Phenomena in Modified Release Lipid Multiparticulates	46
Boosting Oral Chemotherapy Efficacy and Ameliorating Intestinal Dysbiosis via a Microfluidic-Engineered RGD-Targeted Nanoplatform against Breast Cancer	45
Characterization of Human Intestinal Fluids after the Administration of a Solid Meal	45
Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants	44
Immuno-PET Imaging of TNF-α in Colitis Using ⁸⁹Zr-DFO-infliximab	44
Advancing Amorphous Solid Dispersions Design: Insights into Dissolution Kinetics via Thermodynamic Descriptor and Machine Learning	44
Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole	44
Enhanced Therapeutic Efficacy Against Melanoma through Exosomal Delivery of Hesperidin	43
Revolutionizing Neurological Therapies: The Multifaceted Potential of Zein-Based Nanoparticles for Brain-Targeted Drug Delivery	43
Quantitative Characterization of Clinically Relevant Drug-Metabolizing Enzymes and Transporters in Rat Liver and Intestinal Segments for Applications in PBPK Modeling	42
Difference in Endocytosis Pathways Used by Differentiated Versus Nondifferentiated Epithelial Caco-2 Cells to Internalize Nanosized Particles	42
In Vitro Release from Polymeric Core/Shell Nanoparticles through the Lens of Multiscale Modeling	42
Evaluation of a Tumor-Targeting Oligosaccharide Nanosystem in BNCT on an Orthotopic Hepatocellular Carcinoma Model	42
The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA	42
Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement	42
Effect of Moisture Sorption and Lactose Type on Tablet Quality: A Hygroscopicity Study between Lactose Powder and Tablets	42